AU2003270199A1 - Urea compounds active as vanilloid receptor antagonists for the treatment of pain - Google Patents

Urea compounds active as vanilloid receptor antagonists for the treatment of pain

Info

Publication number
AU2003270199A1
AU2003270199A1 AU2003270199A AU2003270199A AU2003270199A1 AU 2003270199 A1 AU2003270199 A1 AU 2003270199A1 AU 2003270199 A AU2003270199 A AU 2003270199A AU 2003270199 A AU2003270199 A AU 2003270199A AU 2003270199 A1 AU2003270199 A1 AU 2003270199A1
Authority
AU
Australia
Prior art keywords
pain
treatment
receptor antagonists
urea compounds
vanilloid receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270199A
Inventor
Gregor James Macdonald
Stephen Frederick Moss
Harshad Kantilal Rami
Mervyn Thompson
David Richard Witty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0221317A external-priority patent/GB0221317D0/en
Priority claimed from GB0305293A external-priority patent/GB0305293D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003270199A1 publication Critical patent/AU2003270199A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003270199A 2002-09-13 2003-09-11 Urea compounds active as vanilloid receptor antagonists for the treatment of pain Abandoned AU2003270199A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0221317.1 2002-09-13
GB0221317A GB0221317D0 (en) 2002-09-13 2002-09-13 Novel compounds
GB0305293A GB0305293D0 (en) 2003-03-07 2003-03-07 Novel compounds
GB0305293.3 2003-03-07
PCT/EP2003/010262 WO2004024710A1 (en) 2002-09-13 2003-09-11 Urea compounds active as vanilloid receptor antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
AU2003270199A1 true AU2003270199A1 (en) 2004-04-30

Family

ID=31995703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270199A Abandoned AU2003270199A1 (en) 2002-09-13 2003-09-11 Urea compounds active as vanilloid receptor antagonists for the treatment of pain

Country Status (2)

Country Link
AU (1) AU2003270199A1 (en)
WO (1) WO2004024710A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI283665B (en) * 2001-09-13 2007-07-11 Smithkline Beecham Plc Novel urea compound, pharmaceutical composition containing the same and its use
US7528151B2 (en) 2003-03-06 2009-05-05 Glaxo Group Limited Heterocyclic urea derivatives for the treatment of pain
JP2006519806A (en) * 2003-03-07 2006-08-31 グラクソ　グループ　リミテッド Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain.
GB0305426D0 (en) 2003-03-08 2003-04-16 Glaxo Group Ltd Novel compounds
SE0301446D0 (en) 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
GB0319150D0 (en) 2003-08-14 2003-09-17 Glaxo Group Ltd Novel compounds
JP4935073B2 (en) 2003-10-14 2012-05-23 味の素株式会社 Ether derivatives
WO2005095327A1 (en) 2004-03-31 2005-10-13 Ajinomoto Co., Inc. Aniline derivatives
EP1773343A4 (en) * 2004-07-13 2009-05-13 Glaxo Group Ltd Antibacterial agents
DE102005023943A1 (en) 2005-05-20 2006-11-23 Grünenthal GmbH Pentafluorosulfanyl-substituted compound and its use for the preparation of medicaments
UY30048A1 (en) 2005-12-23 2007-07-31 Astrazeneca Ab SUBSTITUTED DERIVATIVES OF THE N, 2- (1H-BENZIMIDAZOL-1-IL) ACETAMIDE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
TW200808723A (en) 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase
TWI433839B (en) 2006-08-11 2014-04-11 Neomed Inst New benzimidazole derivatives 290
EP1903037A1 (en) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(hetero)aryl-3-[heteroaryl-piperidin-4yl]-thiourea derivatives as modulators of EP2 receptors
JP5603770B2 (en) 2007-05-31 2014-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング CCR2 receptor antagonist and use thereof
WO2008157575A1 (en) * 2007-06-21 2008-12-24 Irm Llc Protein kinase inhibitors and methods for using thereof
JP5643112B2 (en) 2008-01-28 2014-12-17 アモーレパシフィック コーポレイションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ Novel compounds as vanilloid receptors, isomers or pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing the same
KR101621444B1 (en) 2008-07-02 2016-05-19 (주)아모레퍼시픽 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
EA020548B1 (en) 2008-12-19 2014-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
MX2012006964A (en) 2009-12-17 2012-07-17 Boehringer Ingelheim Int New ccr2 receptor antagonists and uses thereof.
WO2011141477A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP2013526507A (en) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング NOVEL CCR2 RECEPTOR ANTAGONIST, PROCESS FOR PRODUCING THE SAME AND USE THEREOF AS DRUG
US8841313B2 (en) 2010-05-17 2014-09-23 Boehringer Ingelheim International Gmbh CCR2 antagonists and uses thereof
EP2576542B1 (en) 2010-05-25 2015-04-22 Boehringer Ingelheim International GmbH Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases
US8962656B2 (en) 2010-06-01 2015-02-24 Boehringer Ingelheim International Gmbh CCR2 antagonists
JP5786258B2 (en) 2011-07-15 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Novel and selective CCR2 antagonist
JP6917910B2 (en) 2015-07-02 2021-08-11 セントレクシオン セラピューティクス コーポレイション (4-((3R, 4R) -3-methoxytetrahydro-pyran-4-ylamino) piperidine-1-yl) (5-methyl-6-(((2R, 6S) -6- (P-tolyl) tetrahydro) -2H-pyran-2-yl) methylamino) pyrimidine-4yl) metanone citrate
DE102022104759A1 (en) 2022-02-28 2023-08-31 SCi Kontor GmbH Co-crystal screening method, in particular for the production of co-crystals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424761A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants
MXPA03002263A (en) * 2000-09-14 2003-06-24 Schering Corp Substituted urea neuropeptide y y5 receptor antagonists.
GB0110901D0 (en) * 2001-05-02 2001-06-27 Smithkline Beecham Plc Novel Compounds
TWI283665B (en) * 2001-09-13 2007-07-11 Smithkline Beecham Plc Novel urea compound, pharmaceutical composition containing the same and its use
EA007272B1 (en) * 2002-03-13 2006-08-25 Янссен Фармацевтика Н. В. New inhibitors of histone deacetylase

Also Published As

Publication number Publication date
WO2004024710A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2003270199A1 (en) Urea compounds active as vanilloid receptor antagonists for the treatment of pain
IL160755A0 (en) Urea compounds active as vanilloid receptor antagonists for the treatment of pain
NO20034122D0 (en) Amalgamated pyridine derivatives for use as vanilloid receptor antagonists for the treatment of pain
HK1047580A1 (en) Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes.
PT1517609E (en) Fungicidal combinations of active substances
WO2002072536A8 (en) Urea derivatives having vanilloid receptor (vr1) antagonist activity
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
NO20033804L (en) Carbamate compounds for the treatment of pain
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
EP1617847A4 (en) Methods for the controlled delivery of pharmacologically active compounds
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2003259074A1 (en) Gal3 antagonists for the treatment of neuropathic pain
WO2004078101A3 (en) Urea derivatives having vanilloid receptor antagonist activity
AU2003266607A1 (en) Therapeutic agent for rheumatism containing benzamide derivative as active ingredient
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
AU6523200A (en) Vitronectin receptor antagonists useful for the treatment of strokes
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain
AU2002316237A1 (en) Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain
AU2003245995A1 (en) Use of gaba-c receptor antagonists for the treatment of myopia
AU2003208064A1 (en) Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
AU2002324407A1 (en) N-type calcium channel antagonists for the treatment of pain
AU2002326276A1 (en) N-type calcium channel antagonists for the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase